Multiplikator Forward P/S: Inspira Technologies Oxy B.H.N. Ltd. (IINN)

Inspira Technologies - logo grafis emiten IINN

Is it worth investing in Inspira Technologies Oxy (IINN), given the dependence on FDA approvals and R&D costs? This chart on GURU.Markets reflects the forward P/S ratio, with a current value of 56.30, confirming the stability of ventilator assembly despite partial electronics outsourcing. This will result in profit growth driven by the sale of consumables for blood oxygenation systems.

Inspira Technologies - Kapitalisasi marang prakiraan pendapatan IINN (periode 03.10.2025 - 20.05.2026)

Ringkesan rincian data analitis Inspira Technologies (IINN)

Analisis fundamental perusahaan:IINN (inspira-technologies.com)
Sampel barang inspira-technologies.com

Inspira Technologies Oxy's monopoly on molecular blood saturation and strict FDA control determine the high value of future cash flows. The ratio of current market capitalization to projected sales allows for an assessment of the premium paid for the technological barrier, while an analysis of forward capitalization to revenue helps identify asset overheating in time to avoid buying at the peak of market optimism.

Karo sapa Inspira Technologies Oxy saingan

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (Sanuwave Health Inc) - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Outset Medical OM|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep LENSAR Inc. LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Prakiraan rega marang pendapatan|Baird Medical Investment Holdings - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP Medical EDAP|Apyx Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical ICCM|Pulmonx (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio Corp)|Rasio rega marang prakiraan pendapatan cytosorbents.com|Multiplikator forward rega marang pendapatan Sensus Healthcare, Inc. (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan vicarioussurgical.com RBOT|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corp.)|IRIX: Multiplikator forward rega marang pendapatan|ibs.inc - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan PFSA (Profusa Inc.)|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)